Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
ION363, ION363, Artificial Cerebrospinal Fluid (aCSF) for Injection, 5.0 mL (Placebo)
IONIS PHARMACEUTICALS INC
Amyotrophic Lateral Sclerosis with Fused in Sarcoma mutations
1 trial -
Anterior lamellar nanostructured artificial human cornea.
Lxo Ireland Designated Activity Company
Severe Trophic Corneal Ulcers Refractory to Conventional Treatment
1 trial -
Bioengineered Artificial Mesenchimal Sheet (BAMS)
Lxo Ireland Designated Activity Company
Venous Ulcer
1 trial -
ION373, Artificial Cerebrospinal Fluid (aCSF) for injection
IONIS PHARMACEUTICALS INC
Alexander Disease
1 trial -
Hemodialysis with Polymethylmethacrylate Artificial Kidney
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Uremia
1 trial -
Accurate Prediction Artificial Intelligence Models
The First People's Hospital of Lianyungang
Prostate Cancer
1 trial -
Artificial Intelligence Enabled Transvaginal Ultrasound Imaging algorithm
The First People's Hospital of Lianyungang
Ovarian Cancer
1 trial -
Artificial intelligence
Hospital Authority, Hong Kong
Internal Disease
1 trial -
Artificial intelligence in diagnosis
Prime Medicine
Artificial Intelligence (AI) in Diagnosis
1 trial -
Artificial intelligence-assisted chest X-ray in TB screening
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Tuberculosis (TB)
1 trial -
Conventional Artificial Cycle Therapy
Jian Li
Infertility, Female
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources